1. Voineskos D, Daskalakis ZJ, Blumberger DM. Management of Treatment-Resistant Depression: Challenges and Strategies. Neuropsychiatr Dis Treat. 2020 Jan 21;16:221-234. doi: 10.2147/NDT.S198774.
2. López-Muñoz F, D'Ocón P, Romero A, et al. Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery. World J Psychiatry. 2022 Apr 19;12(4):588-602. doi: 10.5498/wjp.v12.i4.588.
3. Alemi F, Min H, Yousefi M, Becker LK, Hane CA, Nori VS, Wojtusiak J. Effectiveness of common antidepressants: a post market release study. EClinicalMedicine. 2021 Oct 25;41:101171. doi: 10.1016/j.eclinm.2021.101171.
4. Arterburn D, Sofer T, Boudreau DM, Bogart A, Westbrook EO, Theis MK, et al. Long-Term Weight Change after Initiating Second-Generation Antidepressants. J Clin Med. 2016 Apr 13;5(4). (https://www.ncbi.nlm.nih.gov/pubmed/27089374)
5. Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ. 2015;h6019. (https://www.bmj.com/content/351/bmj.h6019)
6. Donald M, Partanen R, Sharman L, et al. Long-term antidepressant use in general practice: a qualitative study of GPs' views on discontinuation. Br J Gen Pract. 2021 Jun 24;71(708):e508-e516. doi: 10.3399/BJGP.2020.0913.
7. Voineskos D, Daskalakis ZJ, Blumberger DM. Management of Treatment-Resistant Depression: Challenges and Strategies. Neuropsychiatr Dis Treat. 2020 Jan 21;16:221-234. doi: 10.2147/NDT.S198774.
8. Cuijpers P, Cristea IA, Karyotaki E, et al. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry. 2016 Oct;15(3):245-258. doi: 10.1002/wps.20346.
9. Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N. Psychological therapies for treatment-resistant depression in adults. Cochrane Common Mental Disorders Group, editor. Cochrane Database Syst Rev. 2018 http://doi.wiley.com/10.1002/14651858.CD010558.pub2
10. Dunlop BW, LoParo D, Kinkead B, et al. Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression. Am J Psychiatry. 2019 Apr 1;176(4):275-286. doi: 10.1176/appi.ajp.2018.18091075.
11. Furukawa TA, Weitz ES, Tanaka S, Hollon SD, Hofmann SG, Andersson G, et al. Initial severity of depression and efficacy of cognitive–behavioural therapy: Individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry. 2017; 210(03):190–6. (https://www.ncbi.nlm.nih.gov/pubmed/28104735)
12. Sinyor M, Fefergrad M, Zaretsky A. Cognitive behavioural therapy or antidepressants for acute depression? BMJ. 2015; h6315. (https://www.ncbi.nlm.nih.gov/pubmed/26646303)